Abstract
Background: Heart failure is a common cardiovascular disease. However in Vietnam, the number of publications on the cost of heart failure remains limited, and in particular, there has been no in-depth study on the costs of examinations and medications used by inpatients with heart failure.
Objectives: To analyze the cost of examinations and medications for hospitalized patients with heart failure at the Hue University of Medicine and Pharmacy Hospital.
Materials and methods: A cross-sectional descriptive study was conducted on 204 patients with heart failure at the Hue University of Medicine and Pharmacy Hospital. Data from 2022 to 2023 were retrospectively collected. The cost analysis was performed from the payer’s perspective.
Results: Costs for laboratory tests, diagnostic imaging-functional exploration, and medications accounted for 24.9%, 10.4%, and 22.0% of the total direct medical costs, respectively. NT-ProBNP and echocardiography were the tests and imaging modalities with the highest cost proportions (23.8% and 31.1%, respectively). The proportions of patients undergoing NT-ProBNP testing and echocardiography were 97.1% and 99%, respectively. The antiinfective group accounted for the highest share of total drug cost (54.69%). Regarding heart failure treatment regimens, the most commonly used was the triple combination of foundational drug groups (44.12%). Among heart failure patients, 54.9% were prescribed Sodium Glucose Co-Transporter 2 Inhibitors (SGLT2i), of which
72.32% were patients without comorbid diabetes.
Conclusion: Examinations and medications accounted for a large proportion of the total direct medical costs. Evaluating the implementation of examination services and drug prescriptions is necessary to develop effective cost management strategies in heart failure treatment.
| Published | 2025-12-25 | |
| Fulltext |
|
|
| Language |
|
|
| Issue | Vol. 15 No. 7 (2025) | |
| Section | Original Articles | |
| DOI | 10.34071/jmp.2025.7.12 | |
| Keywords | chi phí, cận lâm sàng, thuốc, suy tim Cost, Examination, Medication, Heart failure |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 Hue Journal of Medicine and Pharmacy
Bozkurt B, Ahmad T, Alexander KM, Baker WL, Bosak K, Breathett K, et al. Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America. J Card Fail. 2023 Oct;29(10):1412–51.
Lippi G, Sanchis-Gomar F. Global epidemiology and future trends of heart failure. AME Medical Journal. 2020 Jun 25;5(0).
Giles L, Freeman C, Field P, Sörstadius E, Kartman B. Humanistic burden and economic impact of heart failure – a systematic review of the literature. F1000Res. 2019 Jun 13;8:859.
Kim E, Kwon HY, Baek SH, Lee H, Yoo BS, Kang SM, et al. Medical costs in patients with heart failure after acute heart failure events: one-year follow-up study. J Med Econ. 2018 Mar;21(3):288–93.
Nguyễn Thị Thu Thủy. Phân tích chi phí trực tiếp y tế trong điều trị mỗi ca nhập viện do duy tim từ dữ liệu thanh toán bảo hiểm y tế Việt Nam năm 2017-2018. Tạp chí Y Học Việt Nam. 2020 May 25;491:tr 93-96.
Ogah OS, Stewart S, Onwujekwe OE, Falase AO, Adebayo SO, Olunuga T, et al. Economic burden of heart failure: investigating outpatient and inpatient costs in Abeokuta, Southwest Nigeria. PLoS One. 2014;9(11):e113032.
Magnussen C, Niiranen TJ, Ojeda FM, Gianfagna F, Blankenberg S, Vartiainen E, et al. Sex-Specific Epidemiology of Heart Failure Risk and Mortality in Europe: Results From the BiomarCaRE Consortium. JACC Heart Fail. 2019 Mar;7(3):204–13.
Phạm Mạnh Hùng. Phân tích chi phí trực tiếp y tế trong điều trị suy tim tại một số bệnh viện chuyên khoa giai đoạn 2020-2022. Tạp chí Y Học Việt Nam. 2023;527(1B):tr 46-50.
Bộ Y tế. Tài liệu chuyên môn “Hướng dẫn chẩn đoán
và điều trị suy tim cấp và mạn”. Quyết định số 1857/QĐBYT. [Online]. 2022; [44 screens]. Nguồn từ: URL: https:// thuvienphapluat.vn/van-ban/The-thao-Y-te/Quyet-dinh1857-QD-BYT-2022-tai-lieu-huong-dan-chan-doan-dieutri-suy-tim-cap-va-man-521118.aspx
Escobar C, Palacios B, Varela L, Gutiérrez M, Duong M, Chen H, et al. Healthcare resource utilization and costs among patients with heart failure with preserved, mildly reduced, and reduced ejection fraction in Spain. BMC Health Services Research. 2022 Oct 8;22(1):1241.
Olchanski N, Vest AR, Cohen JT, Neumann PJ, DeNofrio D. Cost comparison across heart failure patients with reduced and preserved ejection fractions: Analyses of inpatient decompensated heart failure admissions. Int J Cardiol. 2018 Jun 15;261:103–8.
Tổng Cục Thống kê Việt Nam. Biểu chỉ số giá tiêu dùng, chỉ số giá vàng và chỉ số đô la Mỹ tháng 12, Quý IV và 12 tháng năm 2023. [Online]. 2023. [15 screens]. Nguồn từ: URL: https://www.gso.gov.vn/du-lieu-va-so-lieu-thong ke/2023/12/chi-so-gia-tieu-dung-chi-so-gia-vang-va-chi so-gia-do-la-my-thang-12-nam-2023/
Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, et al. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Dec 23;64(24):e139–228.
Eguchi S, Morita Y, Mitani H, Kanegasaki A, Iwasaki K, Yoshikawa T, et al. Burden of Repeated Hospitalizations on Patients with Heart Failure: An Analysis of Administrative and Claims Data in Japan. Drugs Real World Outcomes. 2022 Sep;9(3):377–89.